To investigate whether administration of leptin to rats during pregnancy and lactation affects placental 11b-hydroxysteroid dehydrogenase (11b-HSD2) activity and the susceptibility of their offspring to weight gain and insulin resistance. DESIGN: Pregnant rats fed on a low-protein diet were administered leptin or saline by subcutaneous minipump from day 14 of gestation and throughout lactation. A further group was fed a normal diet and given saline. After weaning, the offspring of each group were fed on a normal diet until 6 weeks of age and then half of each group was transferred to a high-fat diet until 12 months of age. RESULTS: Plasma leptin levels were raised two-fold on days 16-18 of pregnancy in the leptin-treated dams, but, despite a constant rate of infusion, at parturition they dipped to control levels before rising again. The activity of placental 11b-HSD2 was reduced by the low-protein diet; this reduction was prevented by treating the dams with leptin. The male offspring of the salinetreated dams gained more weight and had higher plasma leptin levels on the high fat than the chow diet, but the offspring of the leptin-treated dams did not. Fasting blood glucose and intraperitoneal glucose tolerance at 6 and 12 months of age was unaffected by the high-fat diet, but only the offspring of the leptin-treated dams achieved this control without raised insulin levels. CONCLUSIONS: The rate of leptin clearance appears to increase at parturition. The administration of leptin to rats during late pregnancy and lactation makes their male offspring less susceptible to high-fat-diet-induced weight gain and insulin resistance.
Introduction
Malnutrition during fetal life can increase the susceptibility of adults to insulin resistance and obesity. Thus, the 'thrifty phenotype hypothesis' proposes that when the fetus is nutritionally deprived, it develops an adult phenotype adapted to poor, but not plentiful nutrition. 1 It is based on the evidence that low birthweight is associated with an increased risk of visceral obesity and Type II diabetes in adult life. 1, 2 The increased risk of Type II diabetes is due to both bcell dysfunction and insulin resistance. 3 Insulin resistance and visceral obesity are also features of the metabolic syndrome (insulin resistance syndrome; Syndrome X). 4 Recent reports show that low birthweight due to maternal smoking is also associated with increased obesity in offspring. 5, 6 Glucocorticoids have been proposed to play a role both in programming the fetus to develop the metabolic syndrome 7 and in causing this syndrome in the adult. 8 Moreover, glucocorticoid exposure during late gestation has been linked to b-cell dysfunction and impaired insulin secretion in adult life. 9 High fetal glucocorticoid levels in the small baby syndrome may result from decreased expression of type 2 11b-hydroxysteroid dehydrogenase (11b-HSD2) in the placenta. This enzyme normally protects fetal tissues from the high maternal levels of cortisol (corticosterone in rats) by catalyzing its conversion to inert cortisone (11-dehydrocorticosterone). 7 The small baby syndrome has been modelled in rats by reducing the proportion of protein in their diet (see Holness et al 10 ).
Other approaches that do not model fetal malnutrition, but do produce small pups and a similar metabolic phenotype in adults, are to administer glucocorticoids or 11b-HSD inhibitors to the dam. 7, 11 Indeed, protein malnutrition also reduces placental 11b-HSD2 activity. 12 Leptin may play a role in fetal programming. Circulating leptin levels rise during pregnancy in humans and, according to some studies, in rats. 13, 14 Associated with this rise is the increased expression of leptin mRNA in the placenta in humans 15 and, according to some 14 although not all 16 studies, in rats. Whether the rise in circulating leptin levels is due to increased production in the placenta or adipose tissue, or to increased production of a binding protein that inhibits leptin metabolism is unclear. 17 Most of the leptin produced by the placenta appears, at least in humans, to be released into the maternal circulation. 18, 19 This leptin may affect fetal growth by altering metabolism in the dam. In addition, some placental leptin may reach the fetal circulation 18, 20 and influence fetal growth more directly. Thus, umbilical cord blood leptin levels and placental leptin mRNA correlate with various indices of size at birth. 21, 22 It is also possible that leptin secreted in milk may affect metabolism in the suckling infant 23 and prevent later obesity. 24 Leptin may affect fetal programming by altering exposure of the fetus to glucocorticoids. The administration of leptin prevents endocrine responses to fasting, 25 potently suppressing the secretion of glucocorticoids in vitro 26, 27 and in vivo.
28,29
It seems quite possible that circulating leptin concentrations and, in particular, placental and embryo exposure to leptin may be reduced in mothers where there is fetal growth retardation, particularly if this is induced by diet or protein restriction. We have, therefore, investigated the effect of the administration of leptin to pregnant protein-restricted rats on insulin sensitivity, b-cell function and susceptibility to diet-induced weight gain in their offspring.
Methods

Rats
All animal procedures were conducted under the British Home Office Animals (Scientific Procedures) Act. Pregnant Wistar rats (Charles River, UK Ltd, Margate, UK) (initial weight 200-225 g) were received time-mated at day 1 of gestation (taken when vaginal plugs were detected), housed individually and maintained at 221C on a 12:12 h light:dark cycle. A schematic of the experimental design is shown in Figure 1 . Rats were fed either a diet containing 20% (w/w) protein or an isocaloric diet containing 8% (w/w) protein (Hope Farms, Woerden, Netherlands; the composition and source of the diets were as described previously 30 ) throughout pregnancy and lactation. The deficit in energy due to protein of the low-protein diet was made up by an increase in its carbohydrate content. From day 14 of pregnancy, lowprotein-fed rats were given either saline or murine leptin (2 mg/kg/day in physiological saline; PeproTech EC Ltd, London, UK) via a subcutaneously implanted Alzett minipump (Charles River, UK Ltd, Margate, UK) for 28 days. Normal-protein-fed rats received saline. Spontaneous delivery took place on day 22 of pregnancy after which, at 2 days, litter sizes were standardized to nine for each mother. All maternal measures and pup measurements postweaning were taken in the fed state at 10:00, with plasma levels being measured from tail blood samples. At 21 days of age, all the pups were weaned onto the 20% (w/w) protein diet until 6 weeks of age when half of the pups were transferred to a high-fat diet (Charles River, UK Ltd, Margate, UK; the composition of which (% metabolizable energy) was 20% from protein, 12% from carbohydrate and 68% from fat, as described 31 ). Throughout the study, all the rats were allowed to eat ad libitum and had free access to drinking water. Further investigations were conducted on male rats that had been fasted overnight prior to commencement of procedures, at age 6 and 12 months. The results presented are from the second of two independent experiments, which gave similar results.
Glucose tolerance test
Intraperitoneal glucose tolerance tests were conducted in rats at 6 and 12 months of age. Prior to the procedure, rats were fasted overnight and then dosed with glucose (1 g/kg, i.p.). Blood samples were drawn from the tail for glucose and insulin measurements at 0, 30, 60, 90, 120 and 180 min after glucose injection. Glucose tolerance was assessed in terms of areas under the glucose-time curves. Effect of giving mothers leptin on offspring C Stocker et al Plasma analytes and pancreatic hormone measurements Fasting plasma insulin and leptin were measured by ELISA (Crystal Chem Inc. Immunoassay, Chicago, IL, USA). Blood glucose, triglycerides (Sigma-Aldrich Company, Dorset, UK) and nonesterified fatty acids (ASC-ACOD, Wako Chemicals, Neuss, Germany) were measured colorimetrically. Fed plasma corticosterone levels were measured in the dams by enzyme-immunoassay (IDS OCTEIA Corticosterone immunoassay, Immunodiagnostic Systems, Boldon, UK). For determination of pancreatic insulin, pancreas samples were removed as soon as possible after death. After weighing, they were placed into ice-cold 180 mmol/l hydrochloric acid in 75% (v/v) ethanol (10 ml/g) 32 and minced vigorously. The hormones were extracted overnight at 41C and the extract was separated from the remaining pancreatic tissue by centrifugation at 1800 Â g for 20 min. The pancreatic insulin content was measured using a radioimmunoassay with rat insulin standards and an antiserum raised against rat insulin. The interassay imprecision was 4.8% and the intra-assay imprecision was 1.8%.
Placental 11b-HSD2 activity
There are two isozymes of 11b-HSD. 11b-HSD2 is exclusively a dehydrogenase, whereas 11b-HSD1 is bidirectional with the dehydrogenase activity being most stable in vitro. Consequently, both were assayed in the dehydrogenase direction using their specific cofactors (NADP for HSD1 and NAD for HSD2). Placentas were homogenized in ice-cold PBS (pH 7.4) containing 0.25 M sucrose and assayed for 11b-dehydrogenase activity, as described previously, 33 using a protein concentration of 0.2 mg/ml in whole homogenate of placenta. After a 10-min incubation, steroids were extracted with ethyl acetate and analyzed with thin layer chromatography and high-pressure liquid chromatography against known standards.
Statistics
Glucose tolerance, plasma analyte levels and pancreatic hormone measurements were analyzed using one-way analysis of variance (ANOVA) coupled with Bonferroni's multiple comparison test. An outlier for the 11b-HSD2 results necessitated the use of a nonparametric test (MannWhitney U-test). The results are presented as means7s.e.m.
Results
Effects of leptin administration on pregnant rats fed on a low-protein diet From day 14 of pregnancy, the pregnant rats fed on a normal-protein (20% by weight) diet were given saline via a subcutaneously implanted minipump for 28 days, while those fed on the low (8%)-protein diet were divided into groups given either saline or murine leptin. Plasma leptin levels were doubled on days 16 and 18 of pregnancy in the leptin-treated dams, but at parturition (day 21) they dipped to the levels found in the saline-treated low-protein rats before rising again from days 28 to 43 ( Figure 2a ). Leptin levels were no different in the low-protein and normalprotein saline-treated rats. Leptin reduced food intake during days 16-19 of pregnancy by about 5 g/day (Figure 2b ), but this was not sufficient to elicit a statistically significant reduction in body weight of the dam plus her pups (Figure 2c ), in line with the findings of others in mice. 34 By contrast, after parturition, food intake and body weight were suppressed in both the saline-and leptin-treated low-protein diet groups, compared to the normal-protein diet group (Figure 2b, c) .
The major influence on body weight may have been thermogenesis, which may respond to leptin during pregnancy, but not lactation. 35 Differential sensitivity of energy expenditure and food intake to leptin has been reported previously. 36 It is unlikely that leptin caused weight loss by increasing milk production by the dams, 37 especially since weight gain was low in their offspring. Fasting blood glucose, and plasma insulin, triglyceride and nonesterified fatty acid levels were similar in all three groups of rats up to day 18 of pregnancy (data not shown). Triglyceride levels were elevated on day 21 (preparturition) in both low-protein groups, but returned to the level in the normal-protein diet animals on postpartum day 1 (Figure 2d ). The maternal plasma corticosterone levels rose during pregnancy and fell after parturition in all groups (Figure 2e ).
Placental weight and 11b-HSD activity Placental weights were lower in both the low-protein diet groups than in the normal-protein diet group (Table 1) . The activity of placental type 1 11b-HSD, which converts the inactive glucocorticoid 11-dehydrocorticosterone (cortisone in humans) to active corticosterone (cortisol in humans), was similar in all groups; that of the type 2 enzyme, which converts corticosterone to 11-dehydrocorticosterone, was significantly reduced in the low-protein diet, saline-treated dams, but not in the low-protein diet, leptintreated dams compared to the normal-protein diet group (Figure 2f) . The effect of leptin in the low-protein diet groups was close to statistical significance (P ¼ 0.066; Mann-Whitney U-test).
Raised pancreatic insulin but slow growth in offspring of leptin-treated dams The maternal treatments did not affect litter size (Table 1) but, by 7 days after their birth, pups from both the salineand leptin-treated low-protein dams were smaller than pups from the normal-protein dams, and they remained so through the weaning period (onto the normal-protein diet at age 21-22 days) and until they were 6 weeks old (Figure 3 
The insulin content per gram of pancreas was reduced in 2-day-old pups of saline-treated low-protein dams. Leptin prevented this reduction (Table 1) .
Sensitivity to dietary obesity and hyperinsulinemia in offspring At 6 weeks of age, half the offspring of each group of dams were transferred to a high-fat diet. After 12 weeks on these diets until termination of the experiment, the body weights of the high-fat-fed male rats were raised relative to chow-fed controls, with the exception of the offspring of the leptintreated low-protein diet dams (Figure 4a ). The male offspring of the dams that had been fed on the low-protein diet tended to be shorter in length than those of the normal-protein dams, but administration of leptin to the low-protein dams did not affect length. The high-fat diet increased length only Effect of giving mothers leptin on offspring C Stocker et al in the offspring of the low-protein saline-treated dams ( Table 2) .
Neither the weight gain of the high-fat-fed offspring of the saline-treated dams nor the resistance to weight gain of the offspring of the leptin-treated dams can be explained in terms of energy intake, whether expressed relative to body weight (results not shown) or 38 weekly measurement of food intake. Plasma leptin levels, an indicator of body fat content, were raised by feeding a highfat diet, again with the exception of the offspring of leptintreated dams (Figure 4b ). The offspring of the low-protein diet, saline-treated dams were no more susceptible than offspring of the normal-protein diet, saline-treated dams to weight gain or high leptin levels. Intraperitoneal glucose tolerance tests were conducted when the rats were 6 and 12 months old. The glucose tolerance profile was similar in all groups of 6-and 12-month-old male rats irrespective of dietary treatment (data not shown) as was the overall area under the blood glucosetime profile over 180 min after the glucose load (Figure 5a ). However, with the exception of the offspring of the leptintreated mothers, rats fed on a high-fat diet were hyperinsulinemic. Thus, the integrated insulin concentration during the glucose tolerance did not differ between high-fat-fed and chow-fed offspring of leptin-treated dams, but was significantly increased in the high-fat-fed offspring of control dams that had been fed on either a normal-or a low-protein diet (Figure 5b) .
Fasting glucose concentrations, measured after 4, 20, 30, 40 and 49 weeks on the high-fat diet, were similar in all groups (data not shown). However, fasting insulin levels were raised in the male offspring given the high-fat diet, with the exception of the offspring of the dams that had been treated with leptin (Figure 5c ). Consequently, leptin prevented high-fat feeding from raising the insulin:glucose ratio (Figure 5d ). Like body weight and leptin levels, high-fat feeding had similar effects on insulin levelsFboth fasted and during the glucose tolerance testFin the offspring of normal-and low-protein diet, saline-treated dams.
Discussion
Our results demonstrate that administration of leptin from day 14 of pregnancy and throughout lactation to rats fed on a low-protein (and raised carbohydrate) diet reduces susceptibility to high-fat-diet-induced weight gain and insulin Effect of giving mothers leptin on offspring C Stocker et al resistance in their male adult offspring, despite low birthweight. Leptin also prevented the reduction in islet insulin content in 2-day-old pups of low-protein diet mothers. These effects of leptin were not due to normalization of body weight: from the age of 7 days onwards, the offspring of the leptin-treated dams were the smallest of the three groups. It was recently reported 39 that administration of leptin to pregnant rats reduces both adipose tissue weight at adult age and skeletal growth in their offspring, but in that study leptin was given during the second trimester (days 8, 10 and 12). We found no effect of leptin on nose-to-anus length when it was given from the third trimester. In our study, variable leptin levels were found in the dams despite a constant rate of leptin infusion (Figure 2a ). Very similar results had been obtained in a preliminary experiment. This might be in part explained by a more marked reduction in endogenous leptin synthesis, following parturition in leptin-treated than in control rats. 16 The fall in plasma leptin level was so marked, however, that it seems likely that leptin clearance was greatly increased around the time of parturition. In mice, the circulating concentration of the soluble form of the leptin receptor (Re) is markedly (40-fold) raised in pregnancy and, by binding leptin and inhibiting its metabolism, 40 it appears to be responsible for a rise of similar magnitude in circulating leptin levels. 41 Since placental cells secrete soluble leptin receptor, 42 it is possible that reduced production of a binding protein around the time of parturition greatly enhanced the metabolism of the infused leptin. In addition, there may be a significant clearance of leptin bound to placenta 43 and decidua. Thus in mice, the placenta, decidua and uterus have contents of leptin that approach those of adipose tissue, but only adipose tissue expresses leptin mRNA, 44 suggesting that these tissues bind leptin produced by adipose tissue. To summarize this aspect of the study: the marked fall in plasma leptin levels at parturition, despite continuous leptin infusion, suggests that alterations in the rate of leptin metabolism at this time can have profound effects on plasma leptin levels.
Since leptin levels were raised in the dams during both pregnancy and lactation, we cannot say whether leptin's actions on the offspring were exerted in utero or through its secretion in milk. 23 A direct effect on the offspring of leptin secreted in milk cannot be excluded, 24 but evidence for an in Effect of giving mothers leptin on offspring C Stocker et al utero action derives from leptin's prevention of the lowprotein-diet-induced reduction in placental type 2 11b-HSD activity. The reduced activity of this enzyme has been proposed to make a significant contribution to the small baby (fetal malnutrition) and insulin resistance syndromes. 7, 45 In our study, however, reduced activity of placental type 2 11b-HSD in placentas from the low-protein saline-treated dams was not associated with an increased susceptibility to weight gain and insulin resistance in their offspring. This was not surprising in the light of previous studies: dietary restriction of pregnant rats, but not a lowprotein diet, has been reported to promote obesity in their offspring, 46, 47 while insulin resistance develops slowly and may depend on the precise composition of the diet. 48 The different effects of dietary restriction and a low-protein diet may be because only dietary restriction lowers leptin levels in the pregnant rat. Failure to lower leptin levels may limit the value of the low-protein diet model of maternal malnutrition in humans.
Our results raise the question of the mechanism for the changes in placental type 2 11b-HSD activity. The low level of activity that resulted from the low-protein diet was not due to low circulating leptin levels in the dams: leptin levels were not reduced. Nevertheless, leptin did appear to prevent the reduction in type 2 11b-HSD activity in the low-protein diet rats. This suggests that leptin might have reduced the exposure of the fetuses to corticosterone by promoting its reduction to 11-dehydrocorticosterone. It is possible that, in low-protein diet mothers, this contributed to the subsequent reduced susceptibility to weight gain and insulin resistance. The effect of leptin in pregnant rats on a normal diet will be the subject of a future study.
Overall, our results are consistent with a role for glucocorticoids in programming the fetus to increased susceptibility to the insulin resistance and obesity in later life, but they also suggest that another factor, such as a low leptin level, is involved. Their main importance is that they suggest that it might, conversely, be possible to program offspring in utero or early in life to provide long-term protection from Type II diabetes and obesity.
